Introduction to Sedative-Hypnotics Drugs
Sleep, Introduction to Sedatives -hypnotics, Sedative-hypnotic drug classification, Pharmacology of sedative-hypnotic drugs, Overview, New inventions
Presented by
AGGIM SUMASHREE
Department of Pharmacology
Introduction to General Anaesthetics
Introduction General Anaesthetics, Stages of anaesthesia, Classification of General Anaesthetics, Mechanism of action of General Anaesthetics, Pharmacokinetics, Pharmacodynamics, Uses, Side effects
Presented by
I. Sai Reddemma
Department of Pharmacology
Sympatholytic drugs (Adrenergic blockers) bind to the adrenergic receptors and prevent the action of adrenergic drugs.
These are drugs which block the actions of sympathetic division or catecholamines (adrenaline and noradrenaline).
They are competitive antagonists at both α and β adrenergic receptors.
Adrenergic antagonists are drugs that inhibit the function of adrenergic receptors. There are two main groups - alpha adrenergic blockers and beta adrenergic blockers. Alpha blockers relax smooth muscles in blood vessels and the prostate gland, and are used to treat high blood pressure, BPH, and other conditions. Beta blockers are used to treat high blood pressure, angina, arrhythmias, heart failure, and migraine by blocking the effects of epinephrine and slowing the heart rate. Common alpha blockers discussed are prazosin, tamsulosin, and terazosin, while common beta blockers include propranolol, metoprolol, and aten
Dr. Jibachha Sah,M.V.Sc( Veterinary pharmacology, TU,Nepal),posted lecturer notes on AUTONOMIC AND SYSTEMIC PHARMACOLOGY for B.V.Sc & A.H. 6 th semester veterinary students of College of veterinary science,Nepal Polytechnique Institute, Bharatpur, Bhojard, Chitwan, Nepal.I hope this lecture notes may be beneficial for other Nepalese veterinary students. Please send your comment and suggestion .Email:jibachhashah@gmail.com,moble,00977-9845024121
This document discusses sedative, hypnotic, and anxiolytic drugs. It describes barbiturates and benzodiazepines, which are commonly used as sedative-hypnotics. Barbiturates act by potentiating the inhibitory neurotransmitter GABA, while benzodiazepines facilitate GABA effects by binding to GABAA receptors. The document outlines the mechanisms, effects on sleep, and adverse effects of these drug classes. It also discusses newer nonbenzodiazepine hypnotics and the benzodiazepine antagonist flumazenil.
Neurohumoral transmission in CNS-
The term neurohumoral transmission designates the transfer of a nerve impulse from a presynaptic to a postsynaptic neuron by means of a humoral agent e.g. a biogenic amine, an amino acid or a peptide.
depression ,symptoms, mechanism of depression ,classification of antidepressants , tri cyclic anti depressants and its pharmacological actions ,acute poisoning and treatment
Introduction to General Anaesthetics
Introduction General Anaesthetics, Stages of anaesthesia, Classification of General Anaesthetics, Mechanism of action of General Anaesthetics, Pharmacokinetics, Pharmacodynamics, Uses, Side effects
Presented by
I. Sai Reddemma
Department of Pharmacology
Sympatholytic drugs (Adrenergic blockers) bind to the adrenergic receptors and prevent the action of adrenergic drugs.
These are drugs which block the actions of sympathetic division or catecholamines (adrenaline and noradrenaline).
They are competitive antagonists at both α and β adrenergic receptors.
Adrenergic antagonists are drugs that inhibit the function of adrenergic receptors. There are two main groups - alpha adrenergic blockers and beta adrenergic blockers. Alpha blockers relax smooth muscles in blood vessels and the prostate gland, and are used to treat high blood pressure, BPH, and other conditions. Beta blockers are used to treat high blood pressure, angina, arrhythmias, heart failure, and migraine by blocking the effects of epinephrine and slowing the heart rate. Common alpha blockers discussed are prazosin, tamsulosin, and terazosin, while common beta blockers include propranolol, metoprolol, and aten
Dr. Jibachha Sah,M.V.Sc( Veterinary pharmacology, TU,Nepal),posted lecturer notes on AUTONOMIC AND SYSTEMIC PHARMACOLOGY for B.V.Sc & A.H. 6 th semester veterinary students of College of veterinary science,Nepal Polytechnique Institute, Bharatpur, Bhojard, Chitwan, Nepal.I hope this lecture notes may be beneficial for other Nepalese veterinary students. Please send your comment and suggestion .Email:jibachhashah@gmail.com,moble,00977-9845024121
This document discusses sedative, hypnotic, and anxiolytic drugs. It describes barbiturates and benzodiazepines, which are commonly used as sedative-hypnotics. Barbiturates act by potentiating the inhibitory neurotransmitter GABA, while benzodiazepines facilitate GABA effects by binding to GABAA receptors. The document outlines the mechanisms, effects on sleep, and adverse effects of these drug classes. It also discusses newer nonbenzodiazepine hypnotics and the benzodiazepine antagonist flumazenil.
Neurohumoral transmission in CNS-
The term neurohumoral transmission designates the transfer of a nerve impulse from a presynaptic to a postsynaptic neuron by means of a humoral agent e.g. a biogenic amine, an amino acid or a peptide.
depression ,symptoms, mechanism of depression ,classification of antidepressants , tri cyclic anti depressants and its pharmacological actions ,acute poisoning and treatment
Unit 2 General Pharmacology (As per PCI syllabus)Mirza Anwar Baig
This document provides an overview of drug pharmacology and mechanisms of action. It discusses:
1) Drugs act by interacting with receptors on cells and initiating signal transduction pathways. This allows small drug signals to be amplified within cells.
2) There are four main families of receptors: ligand-gated ion channels, G protein-coupled receptors, enzyme-linked receptors, and intracellular receptors.
3) Drug effects depend on their intrinsic activity as full agonists, partial agonists, inverse agonists or antagonists. Antagonists can be competitive, irreversible or allosteric.
This document summarizes a seminar on sympathomimetic drugs presented by Mohd Fahad and guided by Mohd. Khushtar. It discusses different types of adrenergic drugs including direct, indirect, and mixed acting sympathomimetics. It describes the actions of adrenergic drugs on various organs mediated by alpha and beta receptors. Important drugs are discussed in detail including their uses, doses, preparations, and adverse effects. The document provides an overview of adrenergic pharmacology and the therapeutic uses of sympathomimetic drugs.
Sympathomimetic drugs mimic the actions of norepinephrine and epinephrine by binding to adrenergic receptors. They can be classified as direct-acting agonists like epinephrine, indirect-acting agonists like amphetamines, or mixed-action agonists like ephedrine. Common uses include pressor agents, cardiac stimulants, bronchodilators, nasal decongestants, CNS stimulants, and anorectics. Examples discussed in more detail include epinephrine, norepinephrine, dopamine, dobutamine, ephedrine, amphetamines, phenylephrine, and pseudophedrine.
Drugs used in myasthenia gravis and galucomaAshviniGovande
This document provides information about myasthenia gravis (MG) and drugs used to treat it, as well as information about glaucoma and drugs used to treat glaucoma.
MG is an autoimmune disorder causing muscle weakness due to antibodies blocking acetylcholine receptors at the neuromuscular junction. Drugs used to treat MG include acetylcholinesterase inhibitors like pyridostigmine to increase acetylcholine levels, immunosuppressants to reduce antibody production, and thymectomy to remove the thymus gland source of antibodies.
Glaucoma involves increased fluid pressure in the eye damaging the optic nerve. The most common type is primary open-angle glaucoma. Drugs
Ganglionic stimulants like nicotine can activate nicotinic receptors in autonomic ganglia, resulting in the stimulation of both sympathetic and parasympathetic responses. Although they have limited medical use, nicotine has been used experimentally to help identify nerve fibers. Ganglionic blockers are competitive antagonists at nicotinic receptors that reduce autonomic tone, and were once used to treat hypertension and peptic ulcers but caused intolerable side effects. Trimethaphan is a short-acting ganglionic blocker occasionally used for controlled hypotension. Mecamylamine has been studied for smoking cessation by blocking nicotine's rewarding effects but also causes constipation. Currently there is no significant
Seretonin (5HT) and Its Antagonists PharmacologyPranatiChavan
Serotonin is a chemical that has a wide variety of functions in the human body. It is sometimes called the happy chemical, because it contributes to wellbeing and happiness.
The scientific name for serotonin is 5-hydroxytryptamine, or 5-HT. It is mainly found in the brain, bowels, and blood platelets.
Serotonin is used to transmit messages between nerve cells, it is thought to be active in constricting smooth muscles, and it contributes to wellbeing and happiness, among other things. As the precursor for melatonin, it helps regulate the body’s sleep-wake cycles and the internal clock.
It is thought to play a role in appetite, the emotions, and motor, cognitive, and autonomic functions. However, it is not known exactly if serotonin affects these directly, or if it has an overall role in co-ordinating the nervous system.
Diuretics
Pharmacology
Katzung
Abnormalities in fluid volume and electrolyte composition are common and important clinical disorders. Drugs that block specific transport functions of the renal tubules are valuable clinical tools in the treatment of these disorders. Although various agents that increase urine volume (diuretics) have been described since antiquity, it was not until 1937 that carbonic anhydrase inhibitors were first described and not until 1957 that a much more useful and powerful diuretic agent (chlorothiazide) became available. Technically, a “diuretic” is an agent that increases urine volume, whereas a “natriuretic” causes an increase in renal sodium excretion and an “aquaretic” increases excretion of solute-free water. Because natriuretics almost always also increase water excretion, they are usually called diuretics. Osmotic diuretics and antidiuretic hormone antagonists (see Agents That Alter Water Excretion) are aquaretics that are not directly natriuretic.
Acetylcholinesterase inhibitors : Dr Rahul KunkulolRahul Kunkulol
This document discusses anticholinesterase drugs and their mechanisms and uses. It describes how anticholinesterases inhibit the enzyme acetylcholinesterase, preventing the breakdown of acetylcholine and thereby increasing cholinergic neurotransmission. The main types discussed are reversible carbamate drugs like physostigmine and neostigmine, and irreversible organophosphate inhibitors. Their uses include treating glaucoma, myasthenia gravis, and as antidotes for organophosphate poisoning. The mechanisms and characteristics of specific drugs like physostigmine, neostigmine, and edrophonium are also compared.
This document provides an overview of the pharmacology of dopamine. It discusses dopamine synthesis, receptors, pathways in the brain, and the role of dopamine in conditions like Parkinson's disease, schizophrenia, and addiction. Dopamine is synthesized from phenylalanine and tyrosine and acts on D1-like and D2-like receptors in the mesolimbic, mesocortical, and nigrostriatal pathways. Imbalances in dopaminergic signaling are implicated in disorders such as Parkinson's, schizophrenia, and ADHD. Drugs that modify dopamine transmission are used to treat these conditions.
This document provides information on the pharmacology of diuretics. It begins by explaining that diuretics cause a net loss of sodium and water in urine but sodium balance is restored through homeostatic mechanisms. It then classifies diuretics and describes various classes in detail, including their mechanisms and sites of action, uses, and adverse effects. The classes discussed include high efficacy loop diuretics like furosemide, medium efficacy thiazides, weak carbonic anhydrase inhibitors, potassium sparing aldosterone antagonists, and renal sodium channel inhibitors.
The document discusses drugs used to treat asthma. It describes asthma as a chronic inflammatory airway disorder characterized by wheezing, breathlessness, and reversible airflow obstruction. It outlines the classification of asthma drugs into short-term relievers for acute symptoms and long-term controllers to reduce symptoms and prevent attacks. Short-term relievers include beta-2 adrenergic agonists, methylxanthines, and antimuscarinic agents. Long-term controllers include inhaled corticosteroids, leukotriene pathway antagonists, and mast cell stabilizers.
5-Hydroxytryptamine & it’s Antagonist is a Topic in Pharmacology which will defiantly Help You in pharmacy field All information is related to pharmacology drug acting and it's effect on body. it is collage project given by our department i would like to share with you.
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASEKameshwaran Sugavanam
This document discusses drugs used to treat Alzheimer's disease. It focuses on cholinergic activators like rivastigmine and donepezil, which work by inhibiting the breakdown of acetylcholine in the brain to increase levels of this neurotransmitter that is deficient in Alzheimer's patients. It also discusses memantine, an NMDA receptor antagonist that blocks glutamate receptors and protects nerve cells from damage. Common side effects of these drugs include nausea, diarrhea, vomiting and headaches. The document provides details on the mechanisms and effects of rivastigmine and memantine as two major drug classes used to treat symptoms of Alzheimer's disease.
My all and slides mostly try to simplify pharmacy knowledge. Any time you are free to connect me. It's my pleasure to help you to get simplified pharmacy concepts. You may suggest topics needs to simplify the terminolog
The document discusses narcotic analgesics and antagonists. It describes how narcotic analgesics like morphine bind to opioid receptors in the central and peripheral nervous system to relieve moderate to severe pain. It classifies opioids into natural alkaloids, semisynthetic derivatives, and synthetic compounds. The document outlines the mechanisms of action of opioids like morphine at the mu, kappa, and delta receptors. It also discusses the pharmacological actions, clinical uses, adverse effects, contraindications, and management of acute opioid poisoning of morphine.
Unit 3 Drugs Affecting PNS (As per PCI syllabus)Mirza Anwar Baig
This document provides an overview of a lecture on drugs acting on the autonomic nervous system. It discusses the autonomic neurotransmission and classification of drugs into parasympathomimetics, parasympatholytics, sympathomimetics, and sympatholytics. Specific drugs discussed in detail include direct-acting cholinergic agonists like acetylcholine and indirect-acting cholinergic agonists like anticholinesterase agents. Anticholinergic drugs like atropine are also summarized in terms of their mechanisms and therapeutic uses.
Centrally acting muscle relaxants work in the central nervous system to reduce muscle tone without affecting consciousness. They selectively depress polysynaptic reflexes in the spinal cord and brain that are involved in regulating muscle tone. They also depress pathways in the brainstem that maintain wakefulness, but to a lesser degree. Common classes of centrally acting muscle relaxants include mephenesin congeners, benzodiazepines, GABA mimetics, and central α2 agonists. Examples are carisoprodol, diazepam, baclofen, and tizanidine. These drugs are used to treat muscle spasms, spasticity, and pain conditions involving muscle spasms.
Depression is a mental illness characterized by changes in mood and loss of interest. It has several potential causes like abuse, loss, isolation, stress, or unemployment. There are different types of depression including unipolar, reactive, endogenous, and bipolar. Antidepressants work by increasing neurotransmitters like serotonin, norepinephrine, and dopamine in the brain. Common antidepressants include SSRIs, SNRIs, TCAs, and MAO inhibitors. SSRIs are now the first-line treatment due to their safer side effect profile compared to older TCAs.
Introduction to Opioid analgesis, Terms, History, Classification, Morphine, Opioid receptors, Mechanism of action, Pharmacological actions of morphine, Pharmacokinetics, Adverse effects, Contraindications, Therapeutic uses
Presented by
B . Kranthi Kumar
Department of Pharmacology
Introduction to Pharmacology of Anti-depressants
Classification, Ideal characteristics, Mechanism of action, Pharmacokinetic profile, Indications, Adverse effects, Drug interactions, Contra indications, Current trends, Conclusion
Presented by
G. Sai Swetha
Department of Pharmacology
Unit 2 General Pharmacology (As per PCI syllabus)Mirza Anwar Baig
This document provides an overview of drug pharmacology and mechanisms of action. It discusses:
1) Drugs act by interacting with receptors on cells and initiating signal transduction pathways. This allows small drug signals to be amplified within cells.
2) There are four main families of receptors: ligand-gated ion channels, G protein-coupled receptors, enzyme-linked receptors, and intracellular receptors.
3) Drug effects depend on their intrinsic activity as full agonists, partial agonists, inverse agonists or antagonists. Antagonists can be competitive, irreversible or allosteric.
This document summarizes a seminar on sympathomimetic drugs presented by Mohd Fahad and guided by Mohd. Khushtar. It discusses different types of adrenergic drugs including direct, indirect, and mixed acting sympathomimetics. It describes the actions of adrenergic drugs on various organs mediated by alpha and beta receptors. Important drugs are discussed in detail including their uses, doses, preparations, and adverse effects. The document provides an overview of adrenergic pharmacology and the therapeutic uses of sympathomimetic drugs.
Sympathomimetic drugs mimic the actions of norepinephrine and epinephrine by binding to adrenergic receptors. They can be classified as direct-acting agonists like epinephrine, indirect-acting agonists like amphetamines, or mixed-action agonists like ephedrine. Common uses include pressor agents, cardiac stimulants, bronchodilators, nasal decongestants, CNS stimulants, and anorectics. Examples discussed in more detail include epinephrine, norepinephrine, dopamine, dobutamine, ephedrine, amphetamines, phenylephrine, and pseudophedrine.
Drugs used in myasthenia gravis and galucomaAshviniGovande
This document provides information about myasthenia gravis (MG) and drugs used to treat it, as well as information about glaucoma and drugs used to treat glaucoma.
MG is an autoimmune disorder causing muscle weakness due to antibodies blocking acetylcholine receptors at the neuromuscular junction. Drugs used to treat MG include acetylcholinesterase inhibitors like pyridostigmine to increase acetylcholine levels, immunosuppressants to reduce antibody production, and thymectomy to remove the thymus gland source of antibodies.
Glaucoma involves increased fluid pressure in the eye damaging the optic nerve. The most common type is primary open-angle glaucoma. Drugs
Ganglionic stimulants like nicotine can activate nicotinic receptors in autonomic ganglia, resulting in the stimulation of both sympathetic and parasympathetic responses. Although they have limited medical use, nicotine has been used experimentally to help identify nerve fibers. Ganglionic blockers are competitive antagonists at nicotinic receptors that reduce autonomic tone, and were once used to treat hypertension and peptic ulcers but caused intolerable side effects. Trimethaphan is a short-acting ganglionic blocker occasionally used for controlled hypotension. Mecamylamine has been studied for smoking cessation by blocking nicotine's rewarding effects but also causes constipation. Currently there is no significant
Seretonin (5HT) and Its Antagonists PharmacologyPranatiChavan
Serotonin is a chemical that has a wide variety of functions in the human body. It is sometimes called the happy chemical, because it contributes to wellbeing and happiness.
The scientific name for serotonin is 5-hydroxytryptamine, or 5-HT. It is mainly found in the brain, bowels, and blood platelets.
Serotonin is used to transmit messages between nerve cells, it is thought to be active in constricting smooth muscles, and it contributes to wellbeing and happiness, among other things. As the precursor for melatonin, it helps regulate the body’s sleep-wake cycles and the internal clock.
It is thought to play a role in appetite, the emotions, and motor, cognitive, and autonomic functions. However, it is not known exactly if serotonin affects these directly, or if it has an overall role in co-ordinating the nervous system.
Diuretics
Pharmacology
Katzung
Abnormalities in fluid volume and electrolyte composition are common and important clinical disorders. Drugs that block specific transport functions of the renal tubules are valuable clinical tools in the treatment of these disorders. Although various agents that increase urine volume (diuretics) have been described since antiquity, it was not until 1937 that carbonic anhydrase inhibitors were first described and not until 1957 that a much more useful and powerful diuretic agent (chlorothiazide) became available. Technically, a “diuretic” is an agent that increases urine volume, whereas a “natriuretic” causes an increase in renal sodium excretion and an “aquaretic” increases excretion of solute-free water. Because natriuretics almost always also increase water excretion, they are usually called diuretics. Osmotic diuretics and antidiuretic hormone antagonists (see Agents That Alter Water Excretion) are aquaretics that are not directly natriuretic.
Acetylcholinesterase inhibitors : Dr Rahul KunkulolRahul Kunkulol
This document discusses anticholinesterase drugs and their mechanisms and uses. It describes how anticholinesterases inhibit the enzyme acetylcholinesterase, preventing the breakdown of acetylcholine and thereby increasing cholinergic neurotransmission. The main types discussed are reversible carbamate drugs like physostigmine and neostigmine, and irreversible organophosphate inhibitors. Their uses include treating glaucoma, myasthenia gravis, and as antidotes for organophosphate poisoning. The mechanisms and characteristics of specific drugs like physostigmine, neostigmine, and edrophonium are also compared.
This document provides an overview of the pharmacology of dopamine. It discusses dopamine synthesis, receptors, pathways in the brain, and the role of dopamine in conditions like Parkinson's disease, schizophrenia, and addiction. Dopamine is synthesized from phenylalanine and tyrosine and acts on D1-like and D2-like receptors in the mesolimbic, mesocortical, and nigrostriatal pathways. Imbalances in dopaminergic signaling are implicated in disorders such as Parkinson's, schizophrenia, and ADHD. Drugs that modify dopamine transmission are used to treat these conditions.
This document provides information on the pharmacology of diuretics. It begins by explaining that diuretics cause a net loss of sodium and water in urine but sodium balance is restored through homeostatic mechanisms. It then classifies diuretics and describes various classes in detail, including their mechanisms and sites of action, uses, and adverse effects. The classes discussed include high efficacy loop diuretics like furosemide, medium efficacy thiazides, weak carbonic anhydrase inhibitors, potassium sparing aldosterone antagonists, and renal sodium channel inhibitors.
The document discusses drugs used to treat asthma. It describes asthma as a chronic inflammatory airway disorder characterized by wheezing, breathlessness, and reversible airflow obstruction. It outlines the classification of asthma drugs into short-term relievers for acute symptoms and long-term controllers to reduce symptoms and prevent attacks. Short-term relievers include beta-2 adrenergic agonists, methylxanthines, and antimuscarinic agents. Long-term controllers include inhaled corticosteroids, leukotriene pathway antagonists, and mast cell stabilizers.
5-Hydroxytryptamine & it’s Antagonist is a Topic in Pharmacology which will defiantly Help You in pharmacy field All information is related to pharmacology drug acting and it's effect on body. it is collage project given by our department i would like to share with you.
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASEKameshwaran Sugavanam
This document discusses drugs used to treat Alzheimer's disease. It focuses on cholinergic activators like rivastigmine and donepezil, which work by inhibiting the breakdown of acetylcholine in the brain to increase levels of this neurotransmitter that is deficient in Alzheimer's patients. It also discusses memantine, an NMDA receptor antagonist that blocks glutamate receptors and protects nerve cells from damage. Common side effects of these drugs include nausea, diarrhea, vomiting and headaches. The document provides details on the mechanisms and effects of rivastigmine and memantine as two major drug classes used to treat symptoms of Alzheimer's disease.
My all and slides mostly try to simplify pharmacy knowledge. Any time you are free to connect me. It's my pleasure to help you to get simplified pharmacy concepts. You may suggest topics needs to simplify the terminolog
The document discusses narcotic analgesics and antagonists. It describes how narcotic analgesics like morphine bind to opioid receptors in the central and peripheral nervous system to relieve moderate to severe pain. It classifies opioids into natural alkaloids, semisynthetic derivatives, and synthetic compounds. The document outlines the mechanisms of action of opioids like morphine at the mu, kappa, and delta receptors. It also discusses the pharmacological actions, clinical uses, adverse effects, contraindications, and management of acute opioid poisoning of morphine.
Unit 3 Drugs Affecting PNS (As per PCI syllabus)Mirza Anwar Baig
This document provides an overview of a lecture on drugs acting on the autonomic nervous system. It discusses the autonomic neurotransmission and classification of drugs into parasympathomimetics, parasympatholytics, sympathomimetics, and sympatholytics. Specific drugs discussed in detail include direct-acting cholinergic agonists like acetylcholine and indirect-acting cholinergic agonists like anticholinesterase agents. Anticholinergic drugs like atropine are also summarized in terms of their mechanisms and therapeutic uses.
Centrally acting muscle relaxants work in the central nervous system to reduce muscle tone without affecting consciousness. They selectively depress polysynaptic reflexes in the spinal cord and brain that are involved in regulating muscle tone. They also depress pathways in the brainstem that maintain wakefulness, but to a lesser degree. Common classes of centrally acting muscle relaxants include mephenesin congeners, benzodiazepines, GABA mimetics, and central α2 agonists. Examples are carisoprodol, diazepam, baclofen, and tizanidine. These drugs are used to treat muscle spasms, spasticity, and pain conditions involving muscle spasms.
Depression is a mental illness characterized by changes in mood and loss of interest. It has several potential causes like abuse, loss, isolation, stress, or unemployment. There are different types of depression including unipolar, reactive, endogenous, and bipolar. Antidepressants work by increasing neurotransmitters like serotonin, norepinephrine, and dopamine in the brain. Common antidepressants include SSRIs, SNRIs, TCAs, and MAO inhibitors. SSRIs are now the first-line treatment due to their safer side effect profile compared to older TCAs.
Introduction to Opioid analgesis, Terms, History, Classification, Morphine, Opioid receptors, Mechanism of action, Pharmacological actions of morphine, Pharmacokinetics, Adverse effects, Contraindications, Therapeutic uses
Presented by
B . Kranthi Kumar
Department of Pharmacology
Introduction to Pharmacology of Anti-depressants
Classification, Ideal characteristics, Mechanism of action, Pharmacokinetic profile, Indications, Adverse effects, Drug interactions, Contra indications, Current trends, Conclusion
Presented by
G. Sai Swetha
Department of Pharmacology
Introduction to Histamine and Antihistamine
Role of histamine, Synthesis, Storage, release of histamine
Mechanism of action of histamine
Anti histamine, Therapeutic uses, Adverse effects
Presented by
Shaik Sabeena
Department of Pharmacology
Introduction to Physiological and pathological role of serotonin
Autocoids, Classification, synthesis ,Serotonergic receptors, Physiological actions, Pathophysiological role
Presented by
K.Firdous banu
Department of Pharmacology
Introduction to An Overview of Antipsychotic Drugs
Definition of psychosis, Causes of psychosis, Symptoms of psychosis, Classification of anti psychotic drugs, Mechanism of action, Pharmacokinetics, Adverse effects, Therapeutic uses, Contraindications, New inventions
Presented by
T. Niranjan Reddy
Department of Pharmacology
Introduction to Neuro Degenerative Diseases, Neurodegenerative diseases, Parkinson Disease, Alzhimer’s Disease, Newer Drugs
Presented by
K. THANMAYA DIVYA
Department of Pharmacology
Preclinical Development, Introduction
Definition, Stages of development of a new drug, Objectives of Preclinical studies, Several steps in preclinical trials, Types of studies in Preclinical trials, Importance of preclinical trials
By
Ms. I. Sai Reddemma.
Department of Pharmacology
This document is a seminar presentation on pharmacokinetic parameters given by T. Manish at the Raghavendra Institute of Pharmaceutical Education and Research. The presentation defines pharmacokinetics and pharmacokinetic parameters such as bioavailability, volume of distribution, clearance, and half-life. Factors that influence each parameter are described in detail. The presentation concludes with references used in preparing the seminar.
Introduction to An Overview on Anti-epileptic Drugs,
Introduction to Epilepsy, Types of Seizures, Classification, Mechanism of Action, Pharmacokinetics, Uses, Adverse Effects, Contraindications, New Drugs
Presented by
A. Harsha Vardan Naidu
Department of Pharmacology
Target Validation
Introduction,Drug discovery, Target identification and validation, Target validation and techniques
By
Ms. B. Mary Vishali
Department of Pharmacology
The document summarizes a study that evaluated the effects of probiotic treatment on depression-related behaviors in rats fed either a control or high-fat diet. Key findings include:
1. Probiotic treatment significantly lowered depressive-like behavior in rats and improved performance in memory tests, regardless of diet.
2. Probiotics modulated cytokine production and expression of genes related to the hypothalamic-pituitary-adrenal axis and neuroplasticity.
3. Metabolomic analysis found probiotics significantly affected 13 plasma metabolites involved in immune function, glucose regulation, and neurotransmission.
In this slide contains Monographs of Herbal Drugs Study in British Herbal Pharmacopoeia and American Herbal Pharmacopoeia.
Presented by: M.SUDHEESHNA (Department of pharmaceutical analysis ).RIPER, anantapur
In this slide contains definition, types, causes, inducers and inhibitors, complex drug interactions.
Presented by: SUMASHREE AGGIM (Department of pharmacology).
RIPER, anantapur
The document discusses monographs of herbal drugs from the Siddha and Unani pharmacopoeias. It provides an overview of the Unani pharmacopoeia of India and its monograph format, including sections on nomenclature, description, tests, and specifications. An example of a Unani monograph is given for Habb-e-Mudir. The Siddha pharmacopoeia of India and its monograph format are also reviewed, along with an example Siddha monograph for Amukkaru. References are provided at the end.
In this slide contains the deep explanation of Methods of Determination for Drug-Excipient Compatibility Studies.
Presented by: G.Aravind Kumar (Department of industrial pharmacy),
RIPER, anantapur.
Introduction to Applications of Proteomics Science,
Proteomics- Techniques, Applications of proteomics
Presented by
A. Harsha Vardhan Naidu
Department of Pharmacology
Introduction to Screening Models Of Anti Cancer Drugs
Need for novel anti cancer drugs, In - vitro methods, In - vivo methods, Advantages and disadvantages
Presented by
T. Niranjan Reddy
Department of Pharmacology
Introduction to Anticoagulants
Coagulants, Local agents, Systemic agents, Anticoagulants, Heparin, Low molecular weight heparins, Heparinoids, Oral anticoagulants (Warfarin), Therapeutic uses
Presented by
N. Ramya
Department of Pharmacology
The document describes the development of a new magnetic solid phase extraction (MSPE) adsorbent called polyDOPA@Ag-MNPs for the analysis of trace beta-blockers in biological samples. PolyDOPA@Ag-MNPs were synthesized by reducing silver ions on the surface of magnetic nanoparticles coated with poly(3,4-dihydroxyphenylalanine). The adsorbent was able to isolate beta-blockers from sample matrices using a magnetic field. Optimization of the MSPE method identified pH 7, 2 minutes adsorption time, 4 mg polyDOPA@Ag-MNPs, methanol containing 1% acetic acid as the eluent, 2 minutes elution
JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)
Presented by: K VENKATSAI PRASAD (Department of pharmaceutical analysis and quality assurance).RIPER, anantapur
PPT on Alternate Wetting and Drying presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDSSérgio Sacani
The pathway(s) to seeding the massive black holes (MBHs) that exist at the heart of galaxies in the present and distant Universe remains an unsolved problem. Here we categorise, describe and quantitatively discuss the formation pathways of both light and heavy seeds. We emphasise that the most recent computational models suggest that rather than a bimodal-like mass spectrum between light and heavy seeds with light at one end and heavy at the other that instead a continuum exists. Light seeds being more ubiquitous and the heavier seeds becoming less and less abundant due the rarer environmental conditions required for their formation. We therefore examine the different mechanisms that give rise to different seed mass spectrums. We show how and why the mechanisms that produce the heaviest seeds are also among the rarest events in the Universe and are hence extremely unlikely to be the seeds for the vast majority of the MBH population. We quantify, within the limits of the current large uncertainties in the seeding processes, the expected number densities of the seed mass spectrum. We argue that light seeds must be at least 103 to 105 times more numerous than heavy seeds to explain the MBH population as a whole. Based on our current understanding of the seed population this makes heavy seeds (Mseed > 103 M⊙) a significantly more likely pathway given that heavy seeds have an abundance pattern than is close to and likely in excess of 10−4 compared to light seeds. Finally, we examine the current state-of-the-art in numerical calculations and recent observations and plot a path forward for near-future advances in both domains.
The cost of acquiring information by natural selectionCarl Bergstrom
This is a short talk that I gave at the Banff International Research Station workshop on Modeling and Theory in Population Biology. The idea is to try to understand how the burden of natural selection relates to the amount of information that selection puts into the genome.
It's based on the first part of this research paper:
The cost of information acquisition by natural selection
Ryan Seamus McGee, Olivia Kosterlitz, Artem Kaznatcheev, Benjamin Kerr, Carl T. Bergstrom
bioRxiv 2022.07.02.498577; doi: https://doi.org/10.1101/2022.07.02.498577
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆Sérgio Sacani
Context. The early-type galaxy SDSS J133519.91+072807.4 (hereafter SDSS1335+0728), which had exhibited no prior optical variations during the preceding two decades, began showing significant nuclear variability in the Zwicky Transient Facility (ZTF) alert stream from December 2019 (as ZTF19acnskyy). This variability behaviour, coupled with the host-galaxy properties, suggests that SDSS1335+0728 hosts a ∼ 106M⊙ black hole (BH) that is currently in the process of ‘turning on’. Aims. We present a multi-wavelength photometric analysis and spectroscopic follow-up performed with the aim of better understanding the origin of the nuclear variations detected in SDSS1335+0728. Methods. We used archival photometry (from WISE, 2MASS, SDSS, GALEX, eROSITA) and spectroscopic data (from SDSS and LAMOST) to study the state of SDSS1335+0728 prior to December 2019, and new observations from Swift, SOAR/Goodman, VLT/X-shooter, and Keck/LRIS taken after its turn-on to characterise its current state. We analysed the variability of SDSS1335+0728 in the X-ray/UV/optical/mid-infrared range, modelled its spectral energy distribution prior to and after December 2019, and studied the evolution of its UV/optical spectra. Results. From our multi-wavelength photometric analysis, we find that: (a) since 2021, the UV flux (from Swift/UVOT observations) is four times brighter than the flux reported by GALEX in 2004; (b) since June 2022, the mid-infrared flux has risen more than two times, and the W1−W2 WISE colour has become redder; and (c) since February 2024, the source has begun showing X-ray emission. From our spectroscopic follow-up, we see that (i) the narrow emission line ratios are now consistent with a more energetic ionising continuum; (ii) broad emission lines are not detected; and (iii) the [OIII] line increased its flux ∼ 3.6 years after the first ZTF alert, which implies a relatively compact narrow-line-emitting region. Conclusions. We conclude that the variations observed in SDSS1335+0728 could be either explained by a ∼ 106M⊙ AGN that is just turning on or by an exotic tidal disruption event (TDE). If the former is true, SDSS1335+0728 is one of the strongest cases of an AGNobserved in the process of activating. If the latter were found to be the case, it would correspond to the longest and faintest TDE ever observed (or another class of still unknown nuclear transient). Future observations of SDSS1335+0728 are crucial to further understand its behaviour. Key words. galaxies: active– accretion, accretion discs– galaxies: individual: SDSS J133519.91+072807.4
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
Sedative-Hypnotics Drugs
1. Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
A Seminar as a part of curricular requirement for
M . Pharmacy I year I Semester
Presented by
AGGIM SUMASHREE
(20L81S0102)
Pharmacology
Under the guidance of
A .Sudheer Kumar M.Pharm, (Ph.D)
Assistant Professor
2. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Contents :
Sleep
Introduction to Sedatives -hypnotics
Sedative-hypnotic drug classification
Pharmacology of sedative-hypnotic drugs
Overview
New inventions
References
2
3. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Sleep:
Normal sleep cyclic and repetitive, consists of distinct stages based
on three physiological measures: the electroencephalogram, the
electromyogram and the electronystagmogram.
Non rapid eye movement (NERM)sleep
70%-75%
stage 1,2
stage 3,4:slow wave sleep,sws
Rapid eye movement(REM) sleep
3
4. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
A normal sleep cycle
5. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
• An effective sedative agent should reduce anxiety and exert a calming
effect with little or no effect on motor or mental functions.
• A hypnotic drug produce drowsiness and encourage the onset and
maintenance of a state of sleep that as far as possible resembles the natural
sleep state.
• Hypnotics effects involve more pronounced depression.
• Graded dose-dependent depression of CNS function is a characteristic of
sedative-hypnotics.
Sedatives-hypnotics:
7. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 7
8. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Pharmacology of drugs:
Pharmacology includes
Mechanism of action
Pharmacokinetics
Adverse effects
Therapeutic uses
8
9. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Mechanism of action:
Sedatives-hypnotics
Bind to GABA receptor at different allosteric sites
Facilitates GABA action
Barbiturates increase duration and benodiazepines increase frequency
of opening of cl channel
Membrane hyperpolarization
CNS depression
9
10. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 10
11. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Pharmacokinetics:
Benzodiazipines:
Absorption: orally/I.M/I.V
distribution: pass BBB and Placenta,
secreted into breast milk
Metabolism: in liver by microsomal enzyme
Half-life: long acting-1-3days
short acting-3-8hrs
Intermediate acting-10-20hrs
Excretion: excreted as glucoronide conjugates in urine.
11
12. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Barbiturates :
Absorption: oral/I.V/I.M
Distribution: to all body
Metabolism: Liver
Excretion: alkalinization of the urine expedites the excretion of
barbiturates.
12
13. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Adverse effects :
• Cross placental barrier
• Depression of neonatal vital function
• Detectable in breast milk
• Cvs depression
• Dependence
• Drug-drug interaction
• Pophyria
• Paradoxical excitement in children
13
14. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Therapeutic uses
• Epilepsy in emergency
• Short-term use of sedative-hypnotics for treating anxiety
• Premedication prior to surgery
• Panic and Agoraphobia
• Reduces anxiety and aggression
• Sleep disorder, insomnia
• Treatment of muscle plasticity in cerebral plasy and tetanus
14
15. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
New inventions:
ROZEREM-Ramelteon
• It appears to be a promising novel hypnotic, provided its
efficacy is established.
• It is a MT1 and MT2 Melatonin receptor agonist introduced in
USA and now approved in India.
Meloset, Zytonin, Externex are some of the marketed
melatonin receptor agonist drugs.
15
16. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
Overview :
16
17. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 17
18. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 18
19. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721
References :
• JAMES M. RITTER et,al. “RANG AND DALE’S Textbook of
Pharmacology” 9TH edition 2018 p.577
• KD TRIPATHI “Essentials of Medical Pharmacology Textbook of
pharmacology 7th edition 2013 p.397.
• LUCIA SUKYS-CLAUDINO et al. Braz J Psychiatry Article in
Portuguese 2010 sep- PubMed,gov
19
20. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 20